Ca channel blocker examples
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest examples of calcium channel blockers include Amlodipine, Felodipine, Isradipine, Manidipine, Benidipine, and Ro 40-5967.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Examples of Calcium Channel Blockers
Calcium channel blockers (CCBs) are a class of medications that inhibit the entry of calcium ions into cells through calcium channels. These drugs are widely used in the treatment of various cardiovascular conditions, including hypertension, angina, and arrhythmias. Below are some examples of calcium channel blockers, categorized by their chemical classes and specific effects.
Dihydropyridine Calcium Channel Blockers
Nifedipine, Nicardipine, and Nitrendipine
Nifedipine, nicardipine, and nitrendipine are well-known dihydropyridine calcium channel blockers. These drugs primarily affect the L-type calcium channels, which are crucial for vascular smooth muscle contraction. Nifedipine and nicardipine are particularly effective in reducing blood pressure by causing vasodilation. Nitrendipine has also been shown to block intermediate-conductance Ca2+-activated K+ channels, adding to its pharmacological profile.
Amlodipine and Felodipine
Amlodipine and felodipine are other examples of dihydropyridine CCBs. These medications are used to manage hypertension and angina by inhibiting calcium influx into vascular smooth muscle cells, leading to vasodilation and reduced blood pressure. Amlodipine has also been shown to modulate the expression of genes involved in inflammation, such as interleukin-6 and interleukin-8, in vascular smooth muscle cells.
Benidipine
Benidipine is another dihydropyridine CCB that blocks both L-type and T-type calcium channels. It has been found to stabilize T-type calcium channels in an inactivated state, which contributes to its effectiveness in reducing calcium influx.
Non-Dihydropyridine Calcium Channel Blockers
Verapamil
Verapamil is a phenylalkylamine calcium channel blocker that primarily affects the heart. It is used to treat arrhythmias and hypertension by inhibiting calcium entry into myocardial cells, thereby reducing heart rate and contractility . Verapamil also modulates the expression of genes involved in cholesterol homeostasis and inflammation .
Diltiazem
Diltiazem is a benzothiazepine calcium channel blocker that has both cardiac and vascular effects. It is used to treat angina, hypertension, and certain types of arrhythmias by inhibiting calcium influx into both cardiac and smooth muscle cells.
Other Calcium Channel Blockers
Ro 40-5967
Ro 40-5967 is a non-dihydropyridine calcium channel blocker that inhibits both T-type and L-type calcium channels. It has been shown to block these channels with different mechanisms, contributing to its unique pharmacological profile.
Anthracene-Maleimide Derivatives
Recent research has identified anthracene-maleimide derivatives as new L-type calcium channel blockers. These compounds bind preferentially to inactivated L-type calcium channels, making them potential candidates for the treatment of hypertension.
Conclusion
Calcium channel blockers are a diverse group of medications with various chemical structures and mechanisms of action. Dihydropyridines like nifedipine, amlodipine, and benidipine primarily affect vascular smooth muscle, while non-dihydropyridines like verapamil and diltiazem have significant cardiac effects. Newer compounds, such as anthracene-maleimide derivatives, continue to expand the therapeutic options available for managing cardiovascular diseases.
Sources and full results
Most relevant research papers on this topic
